Boris M. Seletsky

1.4k total citations
17 papers, 579 citations indexed

About

Boris M. Seletsky is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Boris M. Seletsky has authored 17 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Organic Chemistry, 8 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Boris M. Seletsky's work include Cancer Treatment and Pharmacology (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Boris M. Seletsky is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Synthetic Organic Chemistry Methods (5 papers) and Microbial Natural Products and Biosynthesis (4 papers). Boris M. Seletsky collaborates with scholars based in United States, Japan and Switzerland. Boris M. Seletsky's co-authors include Melvin J. Yu, Wanjun Zheng, James A. Marshall, Bruce A. Littlefield, Murray J. Towle, Bruce F. Wels, Kimberley K. Aalfs, Yoshito Kishi, Kathleen A. Salvato and Bryan M. Lewis and has published in prestigious journals such as Angewandte Chemie International Edition, Cancer Research and The Journal of Organic Chemistry.

In The Last Decade

Boris M. Seletsky

15 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boris M. Seletsky United States 12 289 228 165 146 115 17 579
Fiona Hogan United States 6 380 1.3× 298 1.3× 108 0.7× 157 1.1× 84 0.7× 9 637
A. Jonathan Singh New Zealand 16 404 1.4× 321 1.4× 122 0.7× 171 1.2× 200 1.7× 38 800
Kimberley K. Aalfs United States 6 115 0.4× 147 0.6× 117 0.7× 80 0.5× 56 0.5× 6 337
Paul A. Renhowe United States 18 617 2.1× 412 1.8× 83 0.5× 56 0.4× 76 0.7× 26 891
Rolf Jautelat Germany 12 335 1.2× 250 1.1× 62 0.4× 73 0.5× 79 0.7× 21 543
James E. Ray United States 13 326 1.1× 274 1.2× 81 0.5× 94 0.6× 39 0.3× 19 574
Bodo Scheiper Germany 12 609 2.1× 242 1.1× 88 0.5× 62 0.4× 76 0.7× 13 863
Larry Feldberg United States 19 563 1.9× 694 3.0× 132 0.8× 142 1.0× 123 1.1× 25 1.2k
Roger J. Bontems United States 7 247 0.9× 344 1.5× 122 0.7× 194 1.3× 190 1.7× 7 656
Brianne S. Raccor United States 13 237 0.8× 198 0.9× 188 1.1× 151 1.0× 76 0.7× 21 505

Countries citing papers authored by Boris M. Seletsky

Since Specialization
Citations

This map shows the geographic impact of Boris M. Seletsky's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boris M. Seletsky with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boris M. Seletsky more than expected).

Fields of papers citing papers by Boris M. Seletsky

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boris M. Seletsky. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boris M. Seletsky. The network helps show where Boris M. Seletsky may publish in the future.

Co-authorship network of co-authors of Boris M. Seletsky

This figure shows the co-authorship network connecting the top 25 collaborators of Boris M. Seletsky. A scholar is included among the top collaborators of Boris M. Seletsky based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boris M. Seletsky. Boris M. Seletsky is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Agarwala, Kishan, Kenji Kubara, Boris M. Seletsky, Koji Sagane, & Bruce A. Littlefield. (2025). Eribulin's exclusive binding to microtubule plus ends results from discrimination between GTP and GDP forms of β-tubulin. Archives of Biochemistry and Biophysics. 771. 110482–110482.
2.
Yu, Melvin J., Wanjun Zheng, & Boris M. Seletsky. (2013). From micrograms to grams: scale-up synthesis of eribulin mesylate. Natural Product Reports. 30(9). 1158–1158. 86 indexed citations
3.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part II: Orally available and active against resistant tumors in vivo. Bioorganic & Medicinal Chemistry Letters. 21(6). 1634–1638. 12 indexed citations
4.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part I: Compounds containing a lipophilic C32 side chain overcome P-glycoprotein susceptibility. Bioorganic & Medicinal Chemistry Letters. 21(6). 1630–1633. 16 indexed citations
5.
Narayan, Sridhar, Hongsheng Cheng, Hong Du, et al.. (2011). Novel second generation analogs of eribulin. Part III: Blood–brain barrier permeability and in vivo activity in a brain tumor model. Bioorganic & Medicinal Chemistry Letters. 21(6). 1639–1643. 16 indexed citations
6.
Towle, Murray J., Kathleen A. Salvato, Bruce F. Wels, et al.. (2010). Eribulin Induces Irreversible Mitotic Blockade: Implications of Cell-Based Pharmacodynamics for In vivo Efficacy under Intermittent Dosing Conditions. Cancer Research. 71(2). 496–505. 111 indexed citations
7.
Kuznetsov, Galina, Karen TenDyke, Murray J. Towle, et al.. (2009). Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin. Molecular Cancer Therapeutics. 8(10). 2852–2860. 53 indexed citations
8.
Kowalczyk, James J., Mark R. Spyvee, Yang Hu, et al.. (2005). Synthetic analogs of the marine natural product hemiasterlin: Optimization and discovery of E7974, a novel and potent antitumor agent. Cancer Research. 65. 282–282. 3 indexed citations
9.
Seletsky, Boris M., Yuan Wang, Lynn D. Hawkins, et al.. (2004). Structurally simplified macrolactone analogues of halichondrin B. Bioorganic & Medicinal Chemistry Letters. 14(22). 5547–5550. 56 indexed citations
10.
Zheng, Wanjun, Boris M. Seletsky, Monica H. Palme, et al.. (2004). Macrocyclic ketone analogues of halichondrin B. Bioorganic & Medicinal Chemistry Letters. 14(22). 5551–5554. 114 indexed citations
11.
Marshall, James A., et al.. (2000). Addition of Enantioenrichedγ-Oxygenated Allylic Stannanes toN-Acyl Iminium Intermediates: A New Synthesis ofsyn-Amino Alcohol Derivatives. Angewandte Chemie International Edition. 39(5). 953–956. 31 indexed citations
12.
Marshall, James A., et al.. (2000). Addition of Enantioenriched γ-Oxygenated Allylic Stannanes toN-Acyl Iminium Intermediates: A New Synthesis ofsyn-Amino Alcohol Derivatives. Angewandte Chemie. 112(5). 983–986. 5 indexed citations
13.
14.
Oppolzer, Wolfgang, Boris M. Seletsky, & Gérald Bernardinelli. (1994). Asymmetric Diels-Alder reactions of chiral N-methacryloylsultams with 1,3-dienes. Tetrahedron Letters. 35(21). 3509–3512. 13 indexed citations
15.
Marshall, James A., Boris M. Seletsky, & George P. Luke. (1994). Synthesis of Protected Carbohydrate Derivatives Through Homologation of Threose and Erythrose Derivatives with Chiral .gamma.-Alkoxy Allylic Stannanes. The Journal of Organic Chemistry. 59(12). 3413–3420. 36 indexed citations
16.
Marshall, James A., Boris M. Seletsky, & Paul S. Coan. (1994). Highly syn-Selective Additions of Allylic Stannanes to Protected .alpha.-Amino Aldehydes. The Journal of Organic Chemistry. 59(18). 5139–5140. 26 indexed citations
17.
Seletsky, Boris M., Gil Segal, & I. V. Torgov. (1986). Synthesis of Physiologically Active Steroid Esters and Spirolactones. University of Zagreb University Computing Centre (SRCE).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fiona Hogan Breakdown of academic impact, for papers by A. Jonathan Singh Breakdown of academic impact, for papers by Kimberley K. Aalfs Breakdown of academic impact, for papers by Paul A. Renhowe Breakdown of academic impact, for papers by Rolf Jautelat Breakdown of academic impact, for papers by James E. Ray Breakdown of academic impact, for papers by Bodo Scheiper Breakdown of academic impact, for papers by Larry Feldberg Breakdown of academic impact, for papers by Roger J. Bontems Breakdown of academic impact, for papers by Brianne S. Raccor
Rankless by CCL
2026